scholarly journals Epidemiological Correlates and Treatment Outcomes among Patients with MDR Tuberculosis in Northern India

2018 ◽  
Vol 54 (02) ◽  
pp. 090-095
Author(s):  
Anjana Singh ◽  
Ved Prakash ◽  
Ravi Kant

ABSTRACT Introduction: Multi drug resistant-TB (MDR-TB) threatens global TB control and is a major public health concern in several countries. The present study was undertaken to detect the epidemiological correlates and treatment outcomes among patients with MDR-TB previously or currently admitted in Department of Respiratory Medicine and Pulmonary and Critical Medicine, KGMU, Lucknow. Material & Methods: This retrospective study included 2370 TB patients admitted in the Department of Respiratory Medicine and Pulmonary and Critical Medicine, KGMU, Lucknow between years 2012 to 2015. Treatment outcomes were observed. SPSS software was used for data analysis. Results: The total number of MDR-TB cases enrolled were 2370. There were 772 (32.6%) males (95% CI: 30.7 % -34.5%) and 1598 (67.4%) females (95% CI: 65.5% -69.3%) registered for MDR-TB treatment. The treatment outcomes were as follows: majority (77.1%) were under treatment, 279 (11.8%) patients were declared cured, 10 (0.4%) were failure cases, while 64 (2.7%) were defaulters, 149 (6.3%) had died and 41(1.7%) were transferred out. Conclusion: Emergence of MDR-TB has the potential to be a serious public health problem in Northern India and this necessitates strengthening of TB control and improved continuous monitoring of therapy.

2019 ◽  
Author(s):  
Martin Kayitale Mbonye ◽  
John-Paul Otuba ◽  
Sara Riese ◽  
Hilary Alima ◽  
Frank Mugabe ◽  
...  

Abstract Background: Multi-drug resistant – tuberculosis (MDR-TB) is an emerging public health concern in Uganda. Prior to 2013, MDR-TB treatment in Uganda was only provided at the national referral hospital and two private-not-for profit clinics. From 2013, it was scaled up to seven regional referral hospitals (RRH). The aim of this study was to measure interim (six months) treatment outcomes among the first cohort of patients started on MDR-TB treatment at the RRH in Uganda. Methods: This was a cross-sectional study in which a retrospective descriptive analysis of data on a cohort of 69 patients started on MDR-TB treatment at 7 RRH between 1st April 2013 and 30th June 2014 and had been on treatment for at least nine months was conducted. Results: Of the 69 patients, 21 (30.4%) were female, 39 (56.5%) HIV-negative, 30 (43.5%) resistant to both isoniazid and rifampicin and 57 (82.6%) category 1 or 2 drug susceptible TB treatment failures. Median age at start of treatment was 35 years (Interquartile range (IQR): 27-45), median time-to-treatment initiation was 27.5 (IQR:6-89) days and of the 30 HIV-positive patients, 27 (90.0%) were on anti-retroviral treatment with a median CD4 count of 206 cells/microliter of blood (IQR: 113-364.5). Within six months of treatment, 59 (86.0%) patients culture converted, of which 45 (65.2%) converted by the second month and the other 14 (20.3%) by the sixth month; one (1.5%) did not culture convert; three (4.4%) died; and six (8.8%) were lost-to-follow up. Fifty (76.8%) patients experienced at least one drug adverse event, while 40 (67.8%) gained weight. Mean weight gained was 4.7 (standard deviation:3.2) kilograms. Conclusions: Despite MDR-TB treatment initiation delays, most patients had favourable interim treatment outcomes with majority culture converting early and very few getting lost to follow-up. These encouraging interim outcomes indicate a successful scale-up of MDR-TB treatment to RRH.


2021 ◽  
Vol 21 (1) ◽  
Author(s):  
Mbonye Kayitale Martin ◽  
Otuba John Paul ◽  
Riese Sara ◽  
Alima Hilary ◽  
Mugabe Frank ◽  
...  

Abstract Background Multi-drug resistant—tuberculosis (MDR-TB) is an emerging public health concern in Uganda. Prior to 2013, MDR-TB treatment in Uganda was only provided at the national referral hospital and two private-not-for profit clinics. From 2013, it was scaled up to seven regional referral hospitals (RRH). The aim of this study was to measure interim (6 months) treatment outcomes among the first cohort of patients started on MDR-TB treatment at the RRH in Uganda. Methods This was a cross-sectional study in which a descriptive analysis of data collected retrospectively on a cohort of 69 patients started on MDR-TB treatment at six of the seven RRH between 1st April 2013 and 30th June 2014 and had been on treatment for at least 9 months was conducted. Results Of the 69 patients, 21 (30.4%) were female, 39 (56.5%) HIV-negative, 30 (43.5%) resistant to both isoniazid and rifampicin and 57 (82.6%) category 1 or 2 drug susceptible TB treatment failures. Median age at start of treatment was 35 years (Interquartile range (IQR): 27–45), median time-to-treatment initiation was 27.5 (IQR: 6–89) days and of the 30 HIV-positive patients, 27 (90.0%) were on anti-retroviral treatment with a median CD4 count of 206 cells/microliter of blood (IQR: 113–364.5). Within 6 months of treatment, 59 (85.5%) patients culture converted, of which 45 (65.2%) converted by the second month and the other 14 (20.3%) by the sixth month; one (1.5%) did not culture convert; three (4.4%) died; and six (8.8%) were lost-to-follow up. Fifty (76.8%) patients experienced at least one drug adverse event, while 40 (67.8%) gained weight. Mean weight gained was 4.7 (standard deviation: 3.2) kilograms. Conclusions Despite MDR-TB treatment initiation delays, most patients had favourable interim treatment outcomes with majority culture converting early and very few getting lost to follow-up. These encouraging interim outcomes indicate the potential for success of a scale-up of MDR-TB treatment to RRH.


2020 ◽  
Vol 14 (08) ◽  
pp. 893-900
Author(s):  
Barbara Manyame-Murwira ◽  
Kudakwashe Collins Takarinda ◽  
Pruthu Thekkur ◽  
Bright Payera ◽  
Herbert Mutunzi ◽  
...  

Introduction: The isoniazid-resistant TB poses a threat to TB control efforts. Zimbabwe, one of the high TB burden countries, has not explored the burden of isoniazid resistant TB. Hence among all bacteriologically-confirmed TB patients diagnosed in Bulawayo City during March 2017 and December 2018, we aimed to assess the proportion with isoniazid resistant TB and associated factors. Also, we aimed to describe the TB treatment outcomes. Methodology: A cohort study involving routinely collected data by the National TB Reference Laboratory (NTBRL) in Bulawayo City and National TB programme of Zimbabwe. The percentage with 95% confidence interval (CI) was used to express the proportion with isoniazid-resistant TB. The modified Poisson regression was used to assess the association of demographic and clinical characteristics with isoniazid mono-resistant TB. Results: Of 2160 bacteriologically-confirmed TB patients, 1612 (74.6%) had their sputum received at the NTBRL and 743 (46.1%) had culture growth. Among those with culture growth, 34 (4.6%, 95% CI: 3.5-6.7) had isoniazid mono-resistant TB, 25 (3.3%, 95% CI: 2.2-4.9) had MDR-TB. Thus, 59 (7.9%, 95% CI: 6.1-10.1) had isoniazid-resistant TB. Children < 15 years had a higher prevalence of isoniazid mono-resistant TB (aPR= 3.93; 95% CI: 1.24-12.45). Among those with rifampicin sensitive TB, patients with isoniazid-sensitive TB had higher favourable treatment outcomes compared to those with isoniazid-resistant TB (86.3% versus 75.5%, p = 0.039). Conclusions: The prevalence of isoniazid-resistant TB was low compared to neighbouring countries with high burden of TB-HIV. However, Zimbabwe should consider reviewing treatment guidelines for isoniazid mono-resistant TB due to the observed poor treatment outcomes.


2021 ◽  
Vol 11 (1) ◽  
pp. 1-10
Author(s):  
Toga Aldila Cinderatama ◽  
◽  
Ashafidz Fauzan Dianta ◽  
Fery Sofian Efendi ◽  
Kunti Eliyen ◽  
...  

Tuberculosis (TB) is a chronic disease that is still a public health problem globally, including Indonesia, due to its easy transmission. Treatment for TB sufferers consist of several drug combinations that are intended to eradicate germs. For TB sufferers, the key to successful treatment is the patient's compliance with taking medication every day. The lengthy treatment time is usually at least six months allowing non-adherence to taking the medication by the patient. If not treated properly, there will be a risk of disease complications, such as tuberculosis bacteria resistant to drugs, making TB treatment more difficult. In this study, an Android-based was built to remind TB sufferers to take their medication during the treatment process. In addition to the mobile-based application, there is also a web application used by drug drinking supervisors (PMO; Petugas Minum Obat in Indonesia) in monitoring TB patients, where the application can also view patient compliance statistics in taking medication and historical data on TB patients’ medical treatment. After completion and development, the application will be given to PMO officers and patients to be tested. It is hoped that the application can help the TB treatment process become more effective and prevent treatment failure from the implementation.


PLoS Medicine ◽  
2021 ◽  
Vol 18 (7) ◽  
pp. e1003717
Author(s):  
Sarah Yu ◽  
Hojoon Sohn ◽  
Hae-Young Kim ◽  
Hyunwoo Kim ◽  
Kyung-Hyun Oh ◽  
...  

Background Public–private mix (PPM) programs on tuberculosis (TB) have a critical role in engaging and integrating the private sector into the national TB control efforts in order to meet the End TB Strategy targets. South Korea’s PPM program can provide important insights on the long-term impact and policy gaps in the development and expansion of PPM as a nationwide program. Methods and findings Healthcare is privatized in South Korea, and a majority (80.3% in 2009) of TB patients sought care in the private sector. Since 2009, South Korea has rapidly expanded its PPM program coverage under the National Health Insurance (NHI) scheme as a formal national program with dedicated PPM nurses managing TB patients in both the private and public sectors. Using the difference in differences (DID) analytic framework, we compared relative changes in TB treatment outcomes—treatment success (TS) and loss to follow-up (LTFU)—in the private and public sector between the 2009 and 2014 TB patient cohorts. Propensity score matching (PSM) using the kernel method was done to adjust for imbalances in the covariates between the 2 population cohorts. The 2009 cohort included 6,195 (63.0% male, 37.0% female; mean age: 42.1) and 27,396 (56.1% male, 43.9% female; mean age: 45.7) TB patients in the public and private sectors, respectively. The 2014 cohort included 2,803 (63.2% male, 36.8% female; mean age: 50.1) and 29,988 (56.5% male, 43.5% female; mean age: 54.7) patients. In both the private and public sectors, the proportion of patients with transfer history decreased (public: 23.8% to 21.7% and private: 20.8% to 17.6%), and bacteriological confirmed disease increased (public: 48.9% to 62.3% and private: 48.8% to 58.1%) in 2014 compared to 2009. After expanding nationwide PPM, absolute TS rates improved by 9.10% (87.5% to 93.4%) and by 13.6% (from 70.3% to 83.9%) in the public and private sectors. Relative to the public, the private saw 4.1% (95% confidence interval [CI] 2.9% to 5.3%, p-value < 0.001) and −8.7% (95% CI −9.7% to −7.7%, p-value <0.001) higher rates of improvement in TS and reduction in LTFU. Treatment outcomes did not improve in patients who experienced at least 1 transfer during their TB treatment. Study limitations include non-longitudinal nature of our original dataset, inability to assess the regional disparities, and verify PPM program’s impact on TB mortality. Conclusions We found that the nationwide scale-up of the PPM program was associated with improvements in TB treatment outcomes in the private sector in South Korea. Centralized financial governance and regulatory mechanisms were integral in facilitating the integration of highly diverse South Korean private sector into the national TB control program and scaling up of the PPM intervention nationwide. However, TB care gaps continued to exist for patients who transferred at least once during their treatment. These programmatic gaps may be improved through reducing administrative hurdles and making programmatic amendments that can help facilitate management TB patients between institutions and healthcare sectors, as well as across administrative regions.


Author(s):  
Pratibha U. Mulik ◽  
Sudam R. Suryawanshi

Background: After comparing data of NFHS-3 and 4, prevalence of overweight and obesity in women of an urban population almost doubled in 10 yr. So, the causes of increasing prevalence need to be studied as public health concern. Objective of the study is to determine prevalence of overweight and obesity among reproductive age group (15-49 years) of women in an urban slum of Mumbai.Methods: Total 220 women were selected among 11 sectors from A to K by simple random method and data collected by using validated questionnaire. WHO’s classification was used to classify as overweight and obese.Results: Out of 220 women participated in study, 14 (6.36%) were obese, 75 (34.09%) were overweight according to BMI and 17 (7.7%) were found to be obese according to waist to hip ratio. From the present study it was seen that age group of the women, socio economic class, education, history of hypothyroidism, family history of obesity, types of work women do, hours of television watching, calorie and fat intake, had a significant relationship with BMI, whereas physical exercise they used to do and tendency to sleep in the afternoon and hours of sleep in the night had non-significant relationship with BMI.Conclusions: Obesity and overweight is found to be a growing public health problem and can be preventable. Interventional measures include developing healthy eating habits, regular moderate physical exercise, sleeping habits, health camps for screening of overweight and obesity.


2021 ◽  
Vol 5 (2) ◽  
Author(s):  
Marian Evans ◽  
Breanna De Leon ◽  
Reaghan Bathrick ◽  
Annie Ricupero

Background: Unintended pregnancy continues to be a public health concern across the nation. National data demonstrates the highest rates of unintended pregnancy occurs in women who are 18 to 24 years old. Providing practical and meaningful health education about contraception has the potential to reduce unintended pregnancy and improve quality of life for young adults. This paper describes the design and methodology for a comprehensive contraceptive education intervention at a public university. Methods: Convenience sampling was used with a custom survey conducted in Women’s Health classes from 2015-2021. Surveys contained questions about demographic characteristics, knowledge of contraception options, sources of knowledge, stress levels, and confidence in knowledge. Students completed a pretest, received a comprehensive contraception health education lecture, and completed a post-test. Data collection was approved by the university’s IRB, and analyses were conducted using SPSS Version 27. Conclusion: At a time when reproductive freedom, choice, and justice is scrutinized and suppressed, it is imperative that young adults maintain and understand the importance of having control over when, where, and how they decide to have children if they desire to do so. There is a need for continued comprehensive health education and appropriate resources at the university level. The use of assessments, building trusted professor-student relationships, and exploring credible and reliable information sources can be used to reduce the number of unintended pregnancies for college-aged students. If significant, the replication of the design and methods could have a significant impact on the public health problem of unintended pregnancies, maternal health equity, and reproductive justice.


2014 ◽  
Vol 34 (1) ◽  
pp. 39-47 ◽  
Author(s):  
N Mondal

Background: Undernutrition is a major public health concern in many of the developing countries of Asia. Due to immense population size, socioeconomic disparities, illiteracy and inadequate access to health facilities prevalence is very high in India. The objective of this study was to determine the prevalence of age-sex specific thinness (low BMI-for-age) among adolescents residing in rural regions in India. Materials and Methods: This cross-sectional study has conducted among 1165 adolescent (602 boys; 563 girls) aged 10-18 years of Darjeeling district, West Bengal, India. Anthropometric measurements were height and weight obtained and BMI (weight/height2, kg/ m2) was calculated. The prevalence of thinness was assessed using newly proposed age-sex specific cut-offs of Cole et al. The data were analyzed using chi-square, ANOVA and Least Mean and Square (L,M and S) model approach. Results: Prevalence of overall thinness is 49.10% (51.16% boys, 46.89% girls) among rural adolescents. The boys are found to be more sufferer than girls in the different thinness grades include mild (grade I; 27.41% vs. 27.11%), moderate (grade II; 14.62% vs. 12.08%) and severe (grade III; 9.14% vs. 8.70%) (p>0.05). The age and sex specific smooth percentile curves of BMI were derived using L,M and S model approach for further evaluation of nutritional status. Conclusion: The existence of high prevalence of thinness among adolescents indicates nutritional deprivation among rural Indian adolescents. There is an urgent need of appropriate nutritional intervention program to address the public health problem related to undernutrition especially among nutritionally vulnerable segments of adolescents residing in rural regions to ameliorate the nutritional status DOI: http://dx.doi.org/10.3126/jnps.v34i1.8922    J Nepal Paediatr Soc 2014;34(1):39-47


2019 ◽  
Vol 39 (5) ◽  
Author(s):  
Ruolan Bai ◽  
Shuijing Chi ◽  
Xiaofei Li ◽  
Xiting Dai ◽  
Zhenhua Ji ◽  
...  

AbstractTuberculosis (TB) is an infectious disease caused by Mycobacterium tuberculosis (Mtb) which has been threatening global public health for many years. High genetic diversity is dominant feature of Mtb. Increasing cases of multidrug-resistant (MDR) tuberculosis (MDR-TB) is a serious public health problem to TB control in China. Spontaneous mutations in the Mtb genome can alter proteins which are the target of drugs, making the bacteria drug resistant. The purpose of the present study was to analyze the genotype of Mtb isolates from some areas in Yunnan, China and explore the association between genotypes and MDR-TB. Using spoligotyping, we identified Beijing genotypes, six non-Beijing genotypes and a number of orphan genotypes from 270 Mtb isolates from patients in Yunnan Province during 2014–2016. Of 270 Mtb isolates, 102 clinical Mtb strains were identified as drug-resistant (DR) by drug susceptibility testing (DST), among them, 52 MDR strains. Beijing genotypes occupied the highest MDR proportion (78.85%) followed by the orphan genotypes (15.38%). The characteristics of MDR strains showed high genetic diversity. The results will help to efficiently improve diagnosis and treatment and provide valuable information for Mtb molecular epidemiology.


Sign in / Sign up

Export Citation Format

Share Document